RISEDRONATE-DRLA risedronate sodium 5 mg tablets blister pack

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

risedronate sodium, Quantity: 5 mg

Beschikbaar vanaf:

Dr Reddys Laboratories Australia Pty Ltd

INN (Algemene Internationale Benaming):

Risedronate sodium

farmaceutische vorm:

Tablet, film coated

Samenstelling:

Excipient Ingredients: microcrystalline cellulose; povidone; lactose monohydrate; magnesium stearate; crospovidone; titanium dioxide; hypromellose; macrogol 8000; hyprolose; colloidal anhydrous silica; iron oxide yellow; iron oxide red; macrogol 400

Toedieningsweg:

Oral

Eenheden in pakket:

7, 14, 28, 84

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

? Treatment of osteoporosis ,? Treatment of glucocorticoid-induced osteoporosis ,? Preservation of bone mineral density in patients on long term corticosteroid therapy

Product samenvatting:

Visual Identification: Yellow,film coated,round,biconvex tablets,debossed with R5 on one side,plain on the other side; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisatie-status:

Licence status A

Autorisatie datum:

2012-10-03